Which are potentially worrisome adverse effects associated with proton pump inhibitor use in older patients? (Select all that apply)

Choice A reason: Long-term proton pump inhibitor (PPI) use has a weak, controversial association with gastric cancer due to hypergastrinemia, but evidence is inconclusive. In older patients, risks like osteoporosis and nutrient deficiencies are more established and immediate concerns, making this choice less consistently worrisome compared to others. Choice B reason: PPIs reduce gastric acid, impairing calcium absorption, which increases osteoporosis risk in older patients. Chronic use is linked to decreased bone density and higher fracture risk, particularly in the elderly, due to disrupted mineral homeostasis, making this a significant and correct adverse effect to monitor. Choice C reason: PPIs inhibit acid production, reducing absorption of vitamin B12, magnesium, and iron, leading to deficiencies in older patients. These can cause anemia, neurological issues, or hypomagnesemia, which are particularly concerning in the elderly due to comorbidities, making this a correct and critical adverse effect. Choice D reason: Headaches are a possible PPI side effect but are less common and less severe in older patients compared to osteoporosis, nutrient deficiencies, or drug interactions. They don’t pose a significant long-term risk or require specific monitoring, making this choice incorrect for major concerns. Choice E reason: PPIs interact with drugs like clopidogrel, reducing its efficacy by inhibiting CYP2C19, and affect absorption of drugs requiring acidic environments. In older patients with polypharmacy, these interactions increase risks of adverse outcomes, making this a significant and correct concern for PPI use.